Paolo Tarantino: A new ADC is now available to treat the most common subtype of breast cancer - OncoDaily Paolo Tarantino: A new ADC is now available to treat the most common subtype of breast cancer / Breast Cancer, cancer, datopotamab deruxtecan, OncoDaily,

A new ADC is now available to treat the most common subtype of breast cancer - Paolo Tarantino
@ptarantinomd.bsky.social
@fda.gov

oncodaily.com/science/paol...

#BreastCancer #Cancer #DatopotamabDeruxtecan #Medicine #OncoDaily #Oncology #TB01trial #Health